Kyowa Kirin's gene therapy has been revealed as the most expensive drug in the United States, boasting a staggering price tag of $4.3 million. This groundbreaking gene therapy, developed by Kyowa Kirin, is set to revolutionize the treatment landscape for certain medical conditions.
The $4.3 million price tag attached to Kyowa Kirin's gene therapy has sparked discussions and debates within the healthcare industry and among policymakers. The high cost of this treatment has raised concerns about accessibility and affordability for patients who may benefit from it.
